NuGen Medical Devices Inc.
NGMDF
$0.02
$0.00-1.89%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -70.70% | 139.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -70.70% | 139.68% | |||
| Cost of Revenue | -78.63% | 272.45% | |||
| Gross Profit | -58.16% | 56.21% | |||
| SG&A Expenses | 2.42% | -16.58% | |||
| Depreciation & Amortization | -16.59% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.80% | 2.69% | |||
| Operating Income | -0.92% | 1.29% | |||
| Income Before Tax | 68.37% | -171.87% | |||
| Income Tax Expenses | -- | 1,154.55% | |||
| Earnings from Continuing Operations | 68.67% | -175.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 68.67% | -175.10% | |||
| EBIT | -0.92% | 1.29% | |||
| EBITDA | -4.45% | 4.26% | |||
| EPS Basic | 68.90% | -173.33% | |||
| Normalized Basic EPS | 64.44% | -143.24% | |||
| EPS Diluted | 68.90% | -173.33% | |||
| Normalized Diluted EPS | 64.44% | -143.24% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||